133 related articles for article (PubMed ID: 11350011)
21. Effects of isoprostanes and prostanoids on porcine small intestine.
Unmack MA; Rangachari PK; Skadhauge E
J Pharmacol Exp Ther; 2001 Feb; 296(2):434-41. PubMed ID: 11160628
[TBL] [Abstract][Full Text] [Related]
22. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
Marlière S; Cracowski JL; Hakim A; Stanke-Labesque F; Hoffmann P; Bessard G
Can J Physiol Pharmacol; 2005 Jun; 83(6):453-8. PubMed ID: 16049544
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
24. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
[TBL] [Abstract][Full Text] [Related]
25. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
Matsuzaki T; Noguchi K; Nakasone J; Uezu K; Higuchi M; Sakanashi M
Arzneimittelforschung; 1992 Nov; 42(11):1318-22. PubMed ID: 1492844
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1beta-induced hyperresponsiveness to [Sar9,Met(O2)11]substance P in isolated human bronchi.
Barchasz E; Naline E; Molimard M; Moreau J; Georges O; Emonds-Alt X; Advenier C
Eur J Pharmacol; 1999 Aug; 379(1):87-95. PubMed ID: 10499376
[TBL] [Abstract][Full Text] [Related]
27. Augmentation of bovine airway smooth muscle responsiveness to carbachol, KCl, and histamine by the isoprostane 8-iso-PGE2.
Catalli A; Janssen LJ
Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L1035-41. PubMed ID: 15257985
[TBL] [Abstract][Full Text] [Related]
28. Influence of polyunsaturated fatty acids on vasoconstrictions induced by 8-iso-PGF(2alpha) and 8-iso-PGE(2).
Sametz W; Jeschek M; Juan H; Wintersteiger R
Pharmacology; 2000 Apr; 60(3):155-60. PubMed ID: 10754452
[TBL] [Abstract][Full Text] [Related]
29. Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injury.
Brault S; Martinez-Bermudez AK; Marrache AM; Gobeil F; Hou X; Beauchamp M; Quiniou C; Almazan G; Lachance C; Roberts J; Varma DR; Chemtob S
Stroke; 2003 Mar; 34(3):776-82. PubMed ID: 12624307
[TBL] [Abstract][Full Text] [Related]
30. Indirect enhancement of neutrophil activity and adhesion to cultured human umbilical vein endothelial cells by isoprostanes (iPF2alpha-III and iPE2-III).
Zahler S; Becker BF
Prostaglandins Other Lipid Mediat; 1999 Jul; 57(5-6):319-31. PubMed ID: 10480486
[TBL] [Abstract][Full Text] [Related]
31. C-nociceptor sensitization by isoprostanes is cyclooxygenase dependent.
Junger H; Sorkin LS
Brain Res; 2000 Jun; 867(1-2):255-8. PubMed ID: 10837823
[TBL] [Abstract][Full Text] [Related]
32. Effect of isoprostanes on sympathetic neurotransmission in the human isolated iris-ciliary body.
Awe SO; Opere CA; Harris LC; Uketui AJ; Ohia SE
Neurochem Res; 2000 Apr; 25(4):491-6. PubMed ID: 10823581
[TBL] [Abstract][Full Text] [Related]
33. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
Arner M; Högestätt ED; Uski TK
Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
[TBL] [Abstract][Full Text] [Related]
34. Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle.
Janssen LJ; Premji M; Netherton S; Catalli A; Cox G; Keshavjee S; Crankshaw DJ
J Pharmacol Exp Ther; 2000 Nov; 295(2):506-11. PubMed ID: 11046082
[TBL] [Abstract][Full Text] [Related]
35. Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia.
Wilson SH; Best PJ; Lerman LO; Holmes DR; Richardson DM; Lerman A
Cardiovasc Res; 1999 Dec; 44(3):601-7. PubMed ID: 10690293
[TBL] [Abstract][Full Text] [Related]
36. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
37. Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release.
Jourdan KB; Evans TW; Goldstraw P; Mitchell JA
FASEB J; 1999 Jun; 13(9):1025-30. PubMed ID: 10336884
[TBL] [Abstract][Full Text] [Related]
38. 8-Isoprostaglandin F2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats.
Marley R; Harry D; Anand R; Fernando B; Davies S; Moore K
Gastroenterology; 1997 Jan; 112(1):208-13. PubMed ID: 8978361
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: involvement of isoprostanes.
Möbert J; Becker BF
J Am Coll Cardiol; 1998 Jun; 31(7):1687-94. PubMed ID: 9626852
[TBL] [Abstract][Full Text] [Related]
40. Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay.
Bessard J; Cracowski JL; Stanke-Labesque F; Bessard G
J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):333-43. PubMed ID: 11339277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
